Written By: Pharmacally Medical News Desk Pfizer has officially completed the acquisition of Metsera, a biotechnology company known for its next-generation GLP-1 and amylin-based obesity and cardiometabolic drug candidates
Effects may self-resolve, or abate with a reduced dose, gradually increasing back to the therapeutic target
It can be used both during the day and at night
Biol Res Nurs 23(2):280292 Liang M, Pan Y, Zhong T, Zeng Y, Cheng AS (2021) Effects of aerobic, resistance, and combined exercise on metabolic syndrome parameters and cardiovascular risk factors: a systematic review and network meta-analysis
After illnesses involving vomiting, diarrhea, or fever, IV fluids can help restore hydration when someone cannot drink enough fluids
Decreased methylation of the mitochondrial D-loop region in late-onset alzheimer's disease